Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed plus vinorelbine versus vinorelbine in recurrent or metastatic HER2-negative breast cancer
KCT0004573Phase 2Active, not recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed, vinorelbine in breast cancer, sponsored by Seoul National University Hospital. Started Feb 2017; status: active, not recruiting.
02
Drugs
pemetrexedvinorelbine
03
Conditions
breast cancer
Beyond the preview
Go deeper on KCT0004573.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004573.